Aladdin Healthcare Technologies SE

Equities

NMI

DE000A12ULL2

Healthcare Facilities & Services

End-of-day quote BOERSE DUESSELDORF Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
0.0015 ^EUR	0.00%		-62.50%	0.00%

2021	Aladdin Healthcare Technologies Up 28% On OTCBQ Market Listing Approval	MT
2021	Aladdin Healthcare Technologies SE Reports Earnings Results for the Half Year Ended June 30, 2021	CI

Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2020

September 30, 2021 at 06:33 am IST

Aladdin Healthcare Technologies SE announced earnings results for the full year ended December 31, 2020. For the full year, the company announced net loss was EUR 1.232 million compared to EUR 2.989 million a year ago. Basic loss per share from continuing operations was EUR 0.11 compared to EUR 0.26 a year ago.

Latest news about Aladdin Healthcare Technologies SE

Aladdin Healthcare Technologies Up 28% On OTCBQ Market Listing Approval	24/21/24	MT
Aladdin Healthcare Technologies SE Reports Earnings Results for the Half Year Ended June 30, 2021	03/21/03	CI
Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI
Aladdin Healthcare Technologies Jointly Develops Ai-Platform for Cardiovascular Diseases That Achieves Three Patents in China	24/21/24	CI
Aladdin Healthcare Technologies SE Signs Memorandum of Understanding with Consentia Ltd	22/21/22	CI
Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2019	15/20/15	CI
Aladdin Healthcare Technologies SE Discovers Anti-Osteoporosis Nanomolar Activity	09/20/09	CI
Aladdin Healthcare Technologies Completes Biomedical Knowledge Graph for Commercial Use in Drug Development	21/20/21	CI
Aladdin Healthcare Technologies SE Validates Its Proprietary Deep Learning Algorithms	30/20/30	CI
Aladdin Healthcare Technologies SE Develops Fully Automated Deep Learning Process to Detect and Distinguish Covid-19 from Other Diseases from CT Images	20/20/20	CI
Aladdin Healthcare Technologies SE Gains Approval by the Dementias Platform UK for Accessing Important Biobanks Containing A Huge Amount of Medical Data for Dementia Research	17/20/17	CI
Aladdin Healthcare Technologies Sets Up Joint Venture with Chinese Partner Network	30/20/30	CI
Aladdin Healthcare Technologies SE Launches Its Health Risk Assessment Tool to Airbus and Saregama	16/20/16	CI
Aladdin Healthcare Technologies Se Outperforms in the First Quarter 2020 and Achieves Major Milestones Earlier Than Planned	08/20/08	CI
Aladdin Healthcare Technologies SE Launches its Prototype 'Health Risk Assessment Tool' for COVID-19 in India	30/20/30	CI
Aladdin Healthcare Technologies SE Delivers Thermo-Imaging AI System for COVID-19 Coronavirus and Early Virus Mass Detection	26/20/26	CI
Aladdin Healthcare Technologies SE Signs MOU with Partner in India to Validate and Distribute COVID-19 Diagnosis Prototype	16/20/16	CI
Aladdin Healthcare Technologies Develops a Novel Prototype Application for More Accurate Real-Time Diagnosis of Covid-19 Corona Virus	03/20/03	CI
Aladdin Healthcare Technologies SE Announces the Appointment of David C. Rubinsztein as Chief Scientific Advisor	07/20/07	CI
Aladdin Healthcare Technologies SE Develops a Prototype A.I Powered Data Analysis Platform for Brain Imaging	16/20/16	CI
Aladdin Healthcare Technologies SE Release SAAS Prototype for Early Diagnosis of Alzheimer's Disease Based on Blood Test Results	08/20/08	CI
Aladdin Healthcare Technologies SE Announces It Has Entered into A Memorandum of Understanding with Imperial Institute of Advanced Technology	12/19/12	CI
Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2018	23/19/23	CI
Aladdin Healthcare Technologies Signs Partnership Agreement with the Norweigan Centre of Healthy Ageing	21/19/21	CI
Aladdin Healthcare Technologies SE Announces the 2.3 Million Anonymised EMRS on its Platforms Globally	23/19/23	CI

Chart Aladdin Healthcare Technologies SE

Duration

Period

Chart Aladdin Healthcare Technologies SE

More charts

Company Profile

Aladdin Healthcare Technologies SE is a Germany based provider of health care services with the help of Artificial Intelligence. It operates as a healthcare technology company, which develops and builds AI technology diagnostics and health screening services such as blood testing, advanced image processing, and analysis of age-related diseases. The Company serves clients worldwide.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
ALADDIN HEALTHCARE TECHNOLOGIES SE	0.00%	18.62K
HCA HEALTHCARE, INC.	+16.19%	83.4B
CVS HEALTH CORPORATION	-29.26%	72.11B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	27.04B
LABCORP HOLDINGS INC.	-12.89%	16.96B
FRESENIUS SE & CO. KGAA	+1.03%	16.86B
QUEST DIAGNOSTICS INCORPORATED	+1.91%	15.76B
NATERA, INC.	+71.49%	13.33B
REDE D'OR SÃO LUIZ S.A.	+0.73%	12.76B
TENET HEALTHCARE CORPORATION	+70.60%	12.74B

Other Healthcare Facilities & Services